YICHANG HEC CHANGJIANG PHARMACTL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 1558 for the last semiannual is 3.33 B HKD, and it's 8.15% lower compared to the previous semiannual. The net income of H2 23 is 1.04 B HKD.